Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Breast Cancer

Free Subscription Articles published in Am J Surg Retrieve available abstracts of 72 articles: HTML format

Single Articles

April 2024
1. ELSHERIF A, Bernard S, Djohan R, Atallah A, et al
   Nipple necrosis rate with submuscular versus prepectoral implant-based reconstruction in nipple sparing mastectomy: Does it differ?
   Am J Surg. 2024;230:57-62.
   PubMed     Abstract available
   
   
   March 2024
2. JIANG K, Ma C, Yang Y, McKevitt E, et al
   Axillary ultrasonography for early-stage invasive breast cancer.
   Am J Surg. 2024 Mar 8:S0002-9610(24)00171-5. doi: 10.1016/j.amjsurg.2024.
   PubMed     Abstract available
   
   
   
3. DRAPALIK LM, Shenk R, Rock L, Simpson A, et al
   Should breast surgery be considered for patients with de novo metastatic inflammatory breast cancer?
   Am J Surg. 2024 Mar 2:S0002-9610(24)00068-0. doi: 10.1016/j.amjsurg.2024.
   PubMed     Abstract available
   
   
   February 2024
4. CORTINA CS, Kong AL
   Should surgeons reconsider the role of intraoperative sentinel lymph node evaluation for premenopausal breast cancer patients in the era of RxPONDER?
   Am J Surg. 2024 Feb 17:S0002-9610(24)00123-5. doi: 10.1016/j.amjsurg.2024.
   PubMed    
   
   
   
5. ESCANDON JM, Langstein HN, Christiano JG, Aristizabal A, et al
   Latissimus dorsi flap with immediate fat transfer (LIFT) for autologous breast reconstruction: Single institution experience.
   Am J Surg. 2024;228:185-191.
   PubMed     Abstract available
   
   
   January 2024
6. VICKS E, Mason H, Perez Coulter A, Niakan S, et al
   Increased risk of upstage when combinations of breast lesions of uncertain malignant potential are found on core needle biopsy: The need for surgical excision.
   Am J Surg. 2024;227:6-12.
   PubMed     Abstract available
   
   
   
7. LIMBERG J, DiLalla GA
   Increased risk of upstage when combinations of breast lesions of uncertain malignant potential are found on core needle biopsy-The need for surgical excision.
   Am J Surg. 2024;227:4-5.
   PubMed    
   
   
   
8. RECORD SM, Thomas SM, Ntowe K, Chiba A, et al
   BRCA1/2 mutation carriers & risk reducing mastectomy: Who undergoes surgery and potential benefits.
   Am J Surg. 2024;227:146-152.
   PubMed     Abstract available
   
   
   
9. BLUE CM, Ong C, Khan J, Deng X, et al
   Concordant care in sentinel lymph node omission following Choosing Wisely(R) recommendations at a comprehensive cancer center.
   Am J Surg. 2024;227:183-188.
   PubMed     Abstract available
   
   
   
10. DYKES EM, Montgomery KB, Kennedy GD, Krontiras H, et al
    Quality of breast surgery care at a comprehensive cancer center and its rural affiliate hospital.
    Am J Surg. 2024;227:52-56.
    PubMed     Abstract available
    
    
    
11. AITKEN GL, Samuels S, Gannon CJ, Llaguna OH, et al
    Influence of contralateral prophylactic mastectomy on textbook outcome attainment at time of mastectomy.
    Am J Surg. 2024;227:111-116.
    PubMed     Abstract available
    
    
    November 2023
12. ELSHERIF A, Freyvogel Ramirez M, Moore EC, Dietz JR, et al
    Mastectomy margins for ductal carcinoma-in-situ (DCIS): 18 Years of follow-up.
    Am J Surg. 2023;226:646-651.
    PubMed     Abstract available
    
    
    October 2023
13. PESTANA C, Cairns A, Fang-Chi H, Lombana G, et al
    Rates of high-risk screening prior to a breast cancer diagnosis in patients under age 40.
    Am J Surg. 2023 Oct 11:S0002-9610(23)00504-4. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available
    
    
    
14. LUDWIGSON A, Huynh V, Vemuru S, Romandetti K, et al
    Characterizing informational needs and information seeking behavior of patients with breast cancer.
    Am J Surg. 2023 Oct 8:S0002-9610(23)00503-2. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available
    
    
    
15. HOUNSCHELL CA, Kilgore LJ, Pruitt P, Wilder C, et al
    Evaluation of learning curve with Indocyanine Green (IcG) versus blue dye for sentinel lymph node biopsy in breast cancer.
    Am J Surg. 2023 Oct 5:S0002-9610(23)00508-1. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available
    
    
    
16. FEFFERMAN M, Kuchta K, Nicholson K, Attai D, et al
    Patient values in breast cancer surgical decision-making - The WhySurg study.
    Am J Surg. 2023 Oct 4:S0002-9610(23)00517-2. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available
    
    
    
17. NICHOLSON K, Kuchta K, Fefferman M, Pesce C, et al
    Trends in bilateral mastectomy rates among different racial backgrounds: A National Cancer Database study.
    Am J Surg. 2023;226:455-462.
    PubMed     Abstract available
    
    
    
18. KEARSE L, Goll C, Wise B, Yang S, et al
    Promoting breast health awareness: Can a sensor-enabled training system for patient education help?
    Am J Surg. 2023;226:497-501.
    PubMed     Abstract available
    
    
    September 2023
19. HANUSCHAK D, DePiero M, DeMoraes M, Bailly S, et al
    The impact of COVID-19 on patients diagnosed with melanoma, breast, and colorectal cancer.
    Am J Surg. 2023 Sep 29:S0002-9610(23)00496-8. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available
    
    
    
20. MOTT NM, Huynh V, Vemuru S, Parris HJ, et al
    Barriers and facilitators to measuring patient reported outcomes in an academic breast cancer clinic: An application of the RE-AIM framework.
    Am J Surg. 2023 Sep 15:S0002-9610(23)00474-9. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available
    
    
    July 2023
21. MOTEN AS, Grande P, Hendrix A, Fleming MD, et al
    Early-stage breast cancer treatment disparities in the Midsouth: Has anything changed?
    Am J Surg. 2023 Jul 7:S0002-9610(23)00323-9. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available
    
    
    
22. DOREN EL, Park K, Olson J
    Racial disparities in postmastectomy breast reconstruction following implementation of the affordable care act: A systematic review using a minority health and disparities research framework.
    Am J Surg. 2023;226:37-47.
    PubMed     Abstract available
    
    
    
23. CORTINA CS, Kong AL
    Using the tools we have to improve perioperative outcomes for mastectomy patients with severe persistent mental illness.
    Am J Surg. 2023;226:2-3.
    PubMed    
    
    
    June 2023
24. JOEL C, Ciampa M, O'Hara T, Bandera BC, et al
    Effect of three-dimensional intraoperative imaging on surgical outcomes with breast conservation therapy.
    Am J Surg. 2023;225:1009-1012.
    PubMed     Abstract available
    
    
    May 2023
25. CHEN YW, Kim T, Specht MC, Gadd MA, et al
    Time to surgery: A health equity metric in breast cancer patients.
    Am J Surg. 2023 May 25:S0002-9610(23)00210-6. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available
    
    
    
26. WEIGEL RJ
    Dr. Kirby Bland: Breast cancer's biggest enemy.
    Am J Surg. 2023 May 25:S0002-9610(23)00198-8. doi: 10.1016/j.amjsurg.2023.
    PubMed    
    
    
    
27. VASILYEVA E, Nichol A, Bakos B, Barton A, et al
    Breast conserving surgery combined with radiation therapy offers improved survival over mastectomy in early-stage breast cancer.
    Am J Surg. 2023 May 23:S0002-9610(23)00191-5. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available
    
    
    
28. CHUA VH, Chua JH, Aniceto CJ, Antonio JA, et al
    DCIS: When is accelerated partial breast irradiation an option? A meta-analysis on outcomes and eligibility.
    Am J Surg. 2023;225:871-877.
    PubMed     Abstract available
    
    
    
29. DHAK S, Baliski C, Bakos B
    Factors influencing suboptimal pathologic margins and re-excision following breast conserving surgery for ductal carcinoma in-situ.
    Am J Surg. 2023;225:866-870.
    PubMed     Abstract available
    
    
    April 2023
30. DAS S, Jha AK, Kumar M, Singh PK, et al
    Breast Conservation Surgery can become the treatment of choice for Early Breast Cancer?
    Am J Surg. 2023 Apr 14:S0002-9610(23)00148-4. doi: 10.1016/j.amjsurg.2023.
    PubMed    
    
    
    
31. WIENER AA, Neuman HB
    Improving shared decision making in virtual breast cancer surgery consultations.
    Am J Surg. 2023;225:645-649.
    PubMed     Abstract available
    
    
    February 2023
32. SUTTON TL, Patel R, Behrens S, Schwantes I, et al
    Delayed adjuvant endocrine therapy is associated with decreased recurrence-free survival following neoadjuvant chemotherapy for breast cancer.
    Am J Surg. 2023 Feb 24:S0002-9610(23)00088-0. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available
    
    
    
33. GELLINGS JA, Cortina CS, Jorns JM, Johnson MK, et al
    Annual cost-savings with the implementation of estrogen-receptor-only testing on Ductal Carcinoma in Situ specimens.
    Am J Surg. 2023;225:304-308.
    PubMed     Abstract available
    
    
    January 2023
34. REYES A, Torregrosa L, Lozada-Martinez ID, Cabrera-Vargas LF, et al
    Breast cancer mortality research in Latin America: A gap needed to be filled.
    Am J Surg. 2023 Jan 12:S0002-9610(23)00009-0. doi: 10.1016/j.amjsurg.2023.
    PubMed    
    
    
    
35. ESTRADA J, Larson KE, Kilgore LJ, Wagner JL, et al
    Safety of de-escalation of surgical intervention for atypical ductal hyperplasia on percutaneous biopsy: One size does not fit all.
    Am J Surg. 2023;225:21-25.
    PubMed     Abstract available
    
    
    December 2022
36. DESHPANDE AJ, Bhandarkar A, Bobo WV, Bydon M, et al
    Examining the relationship between severe persistent mental illness and surgical outcomes in women undergoing mastectomy for breast cancer.
    Am J Surg. 2022 Dec 28:S0002-9610(22)00827-3. doi: 10.1016/j.amjsurg.2022.
    PubMed     Abstract available
    
    
    
37. ESPOSITO A, Ablah E, Okut H, Tenofsky PL, et al
    Characteristics, treatment and outcomes of HER2 positive male breast cancer.
    Am J Surg. 2022 Dec 9:S0002-9610(22)00791-7. doi: 10.1016/j.amjsurg.2022.
    PubMed     Abstract available
    
    
    
38. ELSHERIF A, Cocco D, Bernard S, Djohan R, et al
    Simultaneous contralateral prophylactic mastectomy compared to unilateral nipple-sparing mastectomy for breast cancer surgical treatment: Are complications higher?
    Am J Surg. 2022 Dec 7:S0002-9610(22)00789-9. doi: 10.1016/j.amjsurg.2022.
    PubMed     Abstract available
    
    
    
39. THOMPSON JL, Wright GP
    Contemporary approaches to the axilla in breast cancer.
    Am J Surg. 2022 Dec 5:S0002-9610(22)00776-0. doi: 10.1016/j.amjsurg.2022.
    PubMed     Abstract available
    
    
    
40. ZHANG C, Kosiorek H, Hammond JB, Jogerst KM, et al
    The impact of mastectomy and reconstruction technique on patient perceived quality of Life.
    Am J Surg. 2022;224:1450-1454.
    PubMed     Abstract available
    
    
    November 2022
41. VALENTE SA, ElSherif A, Tran J, Tu C, et al
    Inflammatory breast cancer and the importance of skin punch biopsy.
    Am J Surg. 2022 Nov 12:S0002-9610(22)00727-9. doi: 10.1016/j.amjsurg.2022.
    PubMed     Abstract available
    
    
    
42. KANDI LA, Hammond JB, Thornburg DA, Jarvis TL, et al
    Can Montgomery tubercles impact aesthetic 3D nipple-areolar complex tattooing? An anatomical, quantitative analysis of breast cancer patients.
    Am J Surg. 2022 Nov 9:S0002-9610(22)00714-0. doi: 10.1016/j.amjsurg.2022.
    PubMed     Abstract available
    
    
    October 2022
43. KO G, Sequeira S, McCready DR, Sarvanantham S, et al
    Utilization of a rapid diagnostic centre during the COVID-19 pandemic reduced diagnostic delays in breast cancer.
    Am J Surg. 2022 Oct 3. pii: S0002-9610(22)00621.
    PubMed     Abstract available
    
    
    
44. CHENG D, Baynosa J, Cross C, Kirgan D, et al
    Comparing the effect of distance to treatment facility on reconstruction and breast conservation therapy for early-stage invasive ductal carcinoma between the nation and the mountain region.
    Am J Surg. 2022;224:1049-1056.
    PubMed     Abstract available
    
    
    September 2022
45. SINGH R, Cao L, Sarode AL, Kharouta M, et al
    Trends in surgery and survival for T1-T2 male breast cancer: A study from the National Cancer Database.
    Am J Surg. 2022 Sep 25. pii: S0002-9610(22)00592.
    PubMed     Abstract available
    
    
    
46. ROONEY MM, Thomas SM, Taskindoust M, Greenup RA, et al
    The role of tumor phenotype in the surgical treatment of early-stage breast cancer.
    Am J Surg. 2022 Sep 22. pii: S0002-9610(22)00576.
    PubMed     Abstract available
    
    
    
47. JATANA S, Zahra S, Miron AD, Antonacci G, et al
    A retrospective study evaluating outcomes of surgical excision versus radiologic follow-up of benign breast papillomas without atypia.
    Am J Surg. 2022;224:932-937.
    PubMed     Abstract available
    
    
    
48. MOHAN SC, Siegel E, Tran H, Ozcan L, et al
    Effects of paravertebral blocks versus liposomal bupivacaine on hospital utilization after mastectomy with reconstruction.
    Am J Surg. 2022;224:938-942.
    PubMed     Abstract available
    
    
    August 2022
49. NNOROM SO, Akinyemi O, Tran J, Baig H, et al
    Color or money?: The impact of socioeconomic status and race/ethnicity on breast cancer mortality.
    Am J Surg. 2022 Aug 24. pii: S0002-9610(22)00456.
    PubMed     Abstract available
    
    
    
50. AZIN A, Tahmasebi H, Brar A, Azin S, et al
    Racial, ethnic and socioeconomic disparities in diagnosis, treatment, and survival of patients with breast cancer.
    Am J Surg. 2022 Aug 5. pii: S0002-9610(22)00448.
    PubMed     Abstract available
    
    
    
51. KRIPALANI S, Kulshreshta S, Saracco B, Meterissian S, et al
    The effect of COVID-19 on breast cancer care and treatment in North America: A scoping review.
    Am J Surg. 2022 Aug 3. pii: S0002-9610(22)00460.
    PubMed     Abstract available
    
    
    
52. WETZEL CL, Gardiner SK, Johnson N, Garreau JR, et al
    Variation in adoption of skin and nipple sparing mastectomy: An opportunity to enhance patient outcomes.
    Am J Surg. 2022;224:710-715.
    PubMed     Abstract available
    
    
    
53. BALISKI C, Bakos B
    Patient reported outcomes following breast conserving surgery are improved by minimizing re-excisions and excessive breast tissue removal.
    Am J Surg. 2022;224:716-721.
    PubMed     Abstract available
    
    
    July 2022
54. HAMMOND JB, Foley BM, Kosiorek HE, Cronin PA, et al
    Seldom one and done: Characterizing rates of reoperation with direct-to-implant breast reconstruction after mastectomy.
    Am J Surg. 2022;224.
    PubMed     Abstract available
    
    
    May 2022
55. FASANO GA, Bayard S, Tamimi R, Bea V, et al
    Impact of the COVID-19 breast cancer screening hiatus on clinical stage and racial disparities in New York City.
    Am J Surg. 2022 May 27. pii: S0002-9610(22)00391.
    PubMed     Abstract available
    
    
    
56. KHUBCHANDANI JA, Greenup RA
    Time to surgery delays: Barriers to care for black women with breast cancer.
    Am J Surg. 2022 May 21. pii: S0002-9610(22)00308.
    PubMed    
    
    
    
57. FAYANJU OM, Fieber JH
    Redressing breast cancer screening disparities during the COVID-19 pandemic: Turning crisis into opportunity.
    Am J Surg. 2022 May 14. pii: S0002-9610(22)00309.
    PubMed    
    
    
    April 2022
58. HEWITT KC, Miller P, Piper M, Prionas N, et al
    Positive margins after mastectomy in patients with invasive lobular carcinoma of the breast: Incidence and management strategies.
    Am J Surg. 2022;223:699-704.
    PubMed     Abstract available
    
    
    March 2022
59. KAPUR H, Bazzarelli A, Warburton R, Pao JS, et al
    Accuracy of preoperative imaging estimates: Opportunities to de-escalate surgery for early invasive breast cancer.
    Am J Surg. 2022 Mar 31. pii: S0002-9610(22)00232.
    PubMed     Abstract available
    
    
    
60. 
    Trends of contralateral prophylactic mastectomy at the time of ipsilateral breast tumor recurrence.
    Am J Surg. 2022;223:538.
    PubMed    
    
    
    
61. KELLY-SCHUETTE KA, Wempe K, Fritz GD, Hop A, et al
    Masculinizing chest surgery for gender affirmation: A retrospective study of outcomes and patient reported satisfaction.
    Am J Surg. 2022;223:577-580.
    PubMed     Abstract available
    
    
    
62. ELSHERIF A, Armanyous S, Gentle CK, Al-Hilli Z, et al
    Trends of Contralateral prophylactic mastectomy at the time of ipsilateral breast tumor recurrence.
    Am J Surg. 2022;223:533-537.
    PubMed     Abstract available
    
    
    February 2022
63. ELSHERIF A, Armanyous S, Valente S
    Mastectomy options for the treatment of breast cancer recurrence after lumpectomy.
    Am J Surg. 2022 Feb 10. pii: S0002-9610(22)00083.
    PubMed    
    
    
    
64. SARGENT RE, Vazquez E, Kang I, Lu J, et al
    Factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer.
    Am J Surg. 2022 Feb 10. pii: S0002-9610(22)00084.
    PubMed    
    
    
    
65. CROWN A, Buchanan C
    My surgical practice: Presenting aesthetic flat closure as an equal option to mastectomy with reconstruction and technical considerations to optimize cosmesis.
    Am J Surg. 2022;223:436-437.
    PubMed    
    
    
    January 2022
66. JOSEPH KA
    Addressing breast cancer surgical disparities using a community-clinical linkage patient navigation model strategy in a NYC hospital system.
    Am J Surg. 2022 Jan 22. pii: S0002-9610(22)00015.
    PubMed    
    
    
    
67. JAIN U, Jain B, Fayanju OM, Chino F, et al
    Disparities in timely treatment among young women with breast cancer.
    Am J Surg. 2022 Jan 22. pii: S0002-9610(22)00020.
    PubMed     Abstract available
    
    
    
68. BECK AC, Fu SL, Liao J, Bashir A, et al
    Risk management recommendations and patient acceptance vary with high-risk breast lesions.
    Am J Surg. 2022;223:94-100.
    PubMed     Abstract available
    
    
    December 2021
69. ELSHERIF A, Armanyous S, Al-Hilli Z, Valente SA, et al
    Mastectomy options for the treatment of ipsilateral breast cancer recurrence after lumpectomy.
    Am J Surg. 2021 Dec 15. pii: S0002-9610(21)00713.
    PubMed     Abstract available
    
    
    November 2021
70. SARGENT RE, Vazquez E, Kang I, Lu J, et al
    Factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer at a safety net medical center.
    Am J Surg. 2021 Nov 16. pii: S0002-9610(21)00676.
    PubMed     Abstract available
    
    
    October 2021
71. CHAGPAR AB, Dupont E, Chiba A, Levine EA, et al
    Are we choosing wisely? Drivers of preoperative MRI use in breast cancer patients.
    Am J Surg. 2021 Oct 23. pii: S0002-9610(21)00620.
    PubMed     Abstract available
    
    
    
72. MANDELBAUM A, Nakhla M, Seo YJ, Dobaria V, et al
    National trends and predictors of mastectomy with immediate breast reconstruction.
    Am J Surg. 2021;222:773-779.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.